China COVID-19: Confirmed Case: New Increase data was reported at 17.000 Person in 10 May 2020. This records an increase from the previous number of 14.000 Person for 09 May 2020. China COVID-19: Confirmed Case: New Increase data is updated daily, averaging 51.000 Person from Jan 2020 (Median) to 10 May 2020, with 112 observations. The data reached an all-time high of 15,152.000 Person in 12 Feb 2020 and a record low of 1.000 Person in 08 May 2020. China COVID-19: Confirmed Case: New Increase data remains active status in CEIC and is reported by National Health Commission. The data is categorized under China Premium Database’s Socio-Demographic – Table CN.GZ: COVID-19: No of Patient.

As of June 6, 2022, the novel coronavirus SARS-CoV-2 that originated in Wuhan, the capital of Hubei province in China, had infected over 2.1 million people and killed 14,612 in the country. Hong Kong is currently the region with the highest active cases in China.

From Wuhan to the rest of China

In late December 2019, health authorities in Wuhan detected several pneumonia cases of unknown cause. Most of these patients had links to the Huanan Seafood Market. With Chinese New Year approaching, millions of Chinese migrant workers travelled back to their hometowns for the celebration. Before the start of the travel ban on January 23, around five million people had left Wuhan. By the end of January, the number of infections had surged to over ten thousand. The death toll from the virus exceeded that of the SARS outbreak a few days later. On February 12, thousands more cases were confirmed in Wuhan after an improvement to the diagnosis method, resulting in another sudden surge of confirmed cases. On March 31, 2020, the National Health Commission (NHC) in China announced that it would begin reporting the infection number of symptom-free individuals who tested positive for coronavirus. On April 17, 2020, health authorities in Wuhan revised its death toll, adding 50 percent more fatalities. After quarantine measures were implemented, the country reported no new local coronavirus COVID-19 transmissions for the first time on March 18, 2020.

The overloaded healthcare system

In Wuhan, 28 hospitals were designated to treat coronavirus patients, but the outbreak continued to test China’s disease control system and most of the hospitals were soon fully occupied. To combat the virus, the government announced plans to build a new hospital swiftly. On February 3, 2020, Huoshenshan Hospital was opened to provide an additional 1,300 beds. Due to an extreme shortage of health-care professionals in Wuhan, thousands of medical staff from all over China came voluntarily to the epicenter to offer their support. After no new deaths reported for first time, China lifted ten-week lockdown on Wuhan on April 8, 2020. Daily life was returning slowly back to normal in the country.

The new SARS-like coronavirus has spread around China since its outbreak in Wuhan - the capital of central China’s Hubei province. As of June 7, 2022, there were 2,785,848 active cases with symptoms in Greater China. The pandemic has caused a significant impact in the country's economy.

Fast-moving epidemic

In Wuhan, over 3.8 thousand deaths were registered in the heart of the outbreak. The total infection number surged on February 12, 2020 in Hubei province. After a change in official methodology for diagnosing and counting cases, thousands of new cases were added to the total figure. There is little knowledge about how the virus that originated from animals transferred to humans. While human-to-human transmission has been confirmed, other transmission routes through aerosol and fecal-oral are also possible. The deaths from the current virus COVID-19 (formally known as 2019-nCoV) has surpassed the toll from the SARS epidemic of 2002 and 2003.

Key moments in the Chinese coronavirus timeline

The doctor in Wuhan, Dr. Li Wenliang, who first warned about the new strain of coronavirus was silenced by the police. It was announced on February 7, 2020 that he died from the effects of the coronavirus infection. His death triggered a national backlash over freedom of speech on Chinese social media. On March 18, 2020, the Chinese government reported no new domestically transmissions for the first time after a series of quarantine and social distancing measures had been implemented. On March 31, 2020, the National Health Commission (NHC) in China started reporting the infection number of symptom-free individuals who tested positive for coronavirus. Before that, asymptomatic cases had not been included in the Chinese official count. China lifted ten-week lockdown on Wuhan on April 8, 2020. Daily life was returning slowly back to normal in the country. On April 17, 2020, health authorities in Wuhan revised its death toll, adding some 1,290 fatalities in its total count.

China recorded 99256991 Coronavirus Cases since the epidemic began, according to the World Health Organization (WHO). In addition, China reported 5226 Coronavirus Deaths. This dataset includes a chart with historical data for China Coronavirus Cases.

China COVID-19: Confirmed Case data was reported at 118,147.000 Person in 08 Jan 2023. This records an increase from the previous number of 104,874.000 Person for 07 Jan 2023. China COVID-19: Confirmed Case data is updated daily, averaging 978.500 Person from Feb 2020 (Median) to 08 Jan 2023, with 1068 observations. The data reached an all-time high of 118,147.000 Person in 08 Jan 2023 and a record low of 55.000 Person in 09 Jun 2020. China COVID-19: Confirmed Case data remains active status in CEIC and is reported by National Health Commission. The data is categorized under High Frequency Database’s Disease Outbreaks – Table CN.GZ: COVID-19: No of Patient.

In past 24 hours, China, Asia had N/A new cases, N/A deaths and N/A recoveries.

Chinese prefectural level governments started to report daily confirmed COVID-19 cases online, starting from January 2020. The disclosures may contain the mobility, potential exposure scenario, epidemiological characteristics, and other useful information of individual cases. We organized a group of content coders since early March 2020, kept monitoring the information updates, manually extracted useful information from the public disclosures, and compiled these datasets.We welcome any form of collaborations with us and non-commercial reuse of our dataset. We highly encourage interested parties to examine the data, report errors in our coding, and help us to keep the data updated.The detailed data description can be found on SSRN preprint server https://dx.doi.org/10.2139/ssrn.3705815.

China recorded 86689 Coronavirus Recovered since the epidemic began, according to the World Health Organization (WHO). In addition, China reported 4636 Coronavirus Deaths. This dataset includes a chart with historical data for China Coronavirus Recovered.

China COVID-19: Number of Death: Year to Date data was reported at 4,633.000 Person in 10 May 2020. This stayed constant from the previous number of 4,633.000 Person for 09 May 2020. China COVID-19: Number of Death: Year to Date data is updated daily, averaging 3,213.000 Person from Jan 2020 (Median) to 10 May 2020, with 113 observations. The data reached an all-time high of 4,633.000 Person in 10 May 2020 and a record low of 4.000 Person in 19 Jan 2020. China COVID-19: Number of Death: Year to Date data remains active status in CEIC and is reported by National Health Commission. The data is categorized under China Premium Database’s Socio-Demographic – Table CN.GZ: COVID-19: No of Death.

A data set on COVID-19 pandemic in China, which covers daily statistics of confirmed cases (new and cumulative), recoveries (new and cumulative) and deaths (new and cumulative) at city/province level. All data are extracted from Chinese government reports and are available in a CSV format.

Content

This dataset includes all-time country-level COVID-19 case count (confirmed, suspected, cured, dead), since 2019-12-01 (currently until 2020-04-20), as a union of two original datasets mentioned below.

For the data in China, province- and city-level data (if reported) are also included.

Data Sources

Data from 2020-01-22 to 2020-04-20 (time-series) https://github.com/BlankerL/DXY-COVID-19-Data - Data is obtained from Ding Xiang Yuan (an online medical social community).

Data from 2019-12-01 to 2020-01-21 https://github.com/canghailan/Wuhan-2019-nCoV - Data from 2019-12-01 to 2020-01-02 is obtained from a scientific paper (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext) - Data from 2020-01-02 to 2020-01-10 is no change. - Data from 2020-01-10 to 2020-01-21 is obtained from official government announcements.

Data Structure

To obtain country-level data: - All countries except China shall have only one record on each time-stamp (field: updateTime). - Due to the hierarchical data structure of China, to obtain country-level level, provinceName == 'China'

To obtain province-level data in China: - countryName == 'China' and provinceEnglishName == (province name) - refer to the field province_confirmedCount

To obtain city-level data in China: - countryName == 'China' and provinceEnglishName == (province name) - It is recommended to use city_zipCode, due to the potential unstandardized data in cityName and cityEnglishName. - Please note that due to the change of

Data Cleaning Done on Original Datasets

NULL values (where exists cityName) in cityEnglishName were filled and other field values were standardized.

NULL values (where exists cityName) in city_zipCode were filled and other field values were standardized.

city_zipCode mapping: details included in 'city data cleaning reference.csv' - 0 for 'Area not defined' - 1 for 'Domestic Import' - 2 for 'International Import' - %99/98/97/96, etc. for areas without separate zip code but specified in reported data

Cover Image

Source of the cover image: https://commons.wikimedia.org/wiki/File:COVID-19_Outbreak_World_Map_(35).svg

Deprecated

Please see https://data.humdata.org/dataset/coronavirus-covid-19-cases-and-deaths for latest COVID-19 stats from the WHO.

Coronavirus COVID-19 cummulative cases and deaths by province for China and aggregated by country for the rest of the World.

A new coronavirus COVID-19 which originated in a seafood market in Wuhan is testing the disease control system in China. According to a survey on the public life and emotional state in China in late ************, the Chinese respondents felt mostly anxious during the outbreak period, but felt more confident and encouraged when thinking about the future.

COVID-19: Number of Death: Hubei: True Up data was reported at 1,290.000 Person in 16 Apr 2020. This records an increase from the previous number of 1.000 Person for 05 Apr 2020. COVID-19: Number of Death: Hubei: True Up data is updated daily, averaging 1.000 Person from Feb 2020 (Median) to 16 Apr 2020, with 3 observations. The data reached an all-time high of 1,290.000 Person in 16 Apr 2020 and a record low of -108.000 Person in 13 Feb 2020. COVID-19: Number of Death: Hubei: True Up data remains active status in CEIC and is reported by National Health Commission. The data is categorized under China Premium Database’s Socio-Demographic – Table CN.GZ: COVID-19: No of Death.

Abstract

The COVID-19 Vaccination Survey in China was conducted in July 2021 to understand refugees' accessibility and willingness to receive a COVID-19 vaccination in China. UNHCR stresses that no one can be left behind in the global effort against COVID-19 and is monitoring the inclusion of refugees and asylum seekers in vaccination plans around the world. At the time, Chinese government policy did not provide free vaccines for foreigners without social security. The survey results however show that this policy was implemented with some flexibility, because among the few that were vaccinated already, more than half received a free COVID-19 vaccine. Some refugees reported difficulties or lack of information about vaccine registration or identity documents to book an appointment. Results further show that even though most are willing to get vaccinated, anti-vaccine sentiments are driven by fear of side effects.

Geographic coverage

The survey covers 24 provinces with most respondents residing in the province of Guangdong.

Analysis unit

Households

Universe

The survey was distributed to all 1017 refugees and asylum seekers.

Kind of data

Census/enumeration data [cen]

Sampling procedure

No sampling was implmented.

Mode of data collection

Self-administered questionnaire: Web-based

Response rate

Out of 1017 distributed surveys, UNHCR received 455 answers (45%). Of those, 30 respondents did not provide consent to participate in the survey.

ObjectiveTo examine the COVID-19 vaccination rate among a representative sample of adults from 31 provinces on the Chinese mainland and identify its influencing factors.MethodsWe gathered sociodemographic information, data on people's awareness and behavior regarding COVID-19 and the COVID-19 vaccine, the accessibility of COVID-19 vaccination services, community environmental factors influencing people's awareness and behavior regarding the vaccination, information about people's skepticism on COVID-19 vaccine, and information about people's trust in doctors as well as vaccine developers through an online nationwide cross-sectional survey among Chinese adults (18 years and older). The odds ratios (OR) and 95% confidence intervals (CI) for the statistical associations were estimated using logistic regression models.ResultsA total of 29,925 participants (51.4% females and 48.6% males) responded. 89.4% of the participants had already received a COVID-19 vaccination. After adjusting for demographic characteristics, awareness of COVID-19 pandemic/ COVID-19 vaccine, community environmental factors, awareness and behavior of general vaccinations, we discovered that having no religious affiliation, having the same occupational status as a result of coronavirus epidemic, being a non-smoker, always engaging in physical activity, having a lower social status, perceiving COVID-19 to be easily curable, and having easier access to vaccination are all associated with high vaccination rate (all P

COVID-19, the coronavirus disease 2019; SARS-CoV-2, the coronavirus 2; ACE2, angiotensin converting enzyme 2; S protein, spiked glycoprotein; TMPRSS2, transmembrane serine protease 2; WHO, World Health Organization.Purpose: Although the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2, has been viably controlled in China, a new normal in healthcare strategies has become standard in China and worldwide. We conducted a questionnaire study to disseminate the experience from China in terms of urology outpatient prevention and control measures under standardized prevention policies against COVID-19.Participants and Methods: From May 3, 2020 to June 25, 2020, we conducted an anonymous cross-sectional questionnaire study, focused on the status of and experiences with outpatient urology prevention and control measures during the COVID-19 pandemic. The targeted respondents were urologists in mainland China, covering all levels of hospitals and clinics.Results: A total of 216 (97%) valid responses were collected. We found that 183 (85%) respondents were from outside of Hubei province in China. One-hundred-and-fifty-eight (73%) respondents believed that SARS-CoV-2 could be detected in urine, and that protection against urine exposure was needed. Over 80% of respondents recommended WeChat application or similar online video meetings for virtual outpatient consultations. The suggested flowcharts and recommendations to prevent new cases were easy to understand and approved by most physicians, which could provide reference for outpatient prevention and control. We still need to make adequate preparations under the new normal of the COVID-19 Epidemic, especially for those suspected of being infected.Conclusions: Although the scientific validation of the questionnaire is limited, it provides a first snapshot of the experiences relating to the prevention and control measures in urology clinics in China, and can inform future policies in this field.

COVID-19 has become one of the largest epidemics in the world. As of February 20, 2020, the crude fatality rate of novel coronavirus COVID-19 among patients who had cardiovascular diseases ranged around 13.2 percent in China. The figure was based on a medical analysis of 55,924 confirmed infections with 2,114 death cases.

The novel coronavirus that originated in the Chinese city Wuhan - the capital of Hubei province - had killed 17,826 people in Greater China. As of June 7, 2022, there were 2,785,848 active cases with symptoms in the region.

How did it spread?

In late December 2019, the health authorities in Wuhan detected several pneumonia cases of unknown cause. Most of these patients had links to the Huanan seafood market. The virus then spread spread rapidly to other provinces when millions of Chinese migrant workers headed home for Chinese New Year celebrations. About five billion people left Wuhan before the start of the travel ban on January 23. Right before Chinese New Year, the central government decided to put Wuhan and other cities in Hubei province on lockdown. With further travel restrictions and cancellations of public celebration events, the number of infections surpassed 80 thousand by the end of February. On March 18, 2020, China reported no new local coronavirus COVID-19 transmissions for the first time after quarantine measures had been implemented. On March 31, 2020, the National Health Commission (NHC) in China announced that it would begin reporting the infection number of symptom-free individuals who tested positive for coronavirus. After no new deaths reported for first time, the Chinese government lifted ten-week lockdown on Wuhan on April 8, 2020. Daily life was returning slowly back to normal in the country.

What is COVID-19?

Coronaviruses originate in animals like camels, civets and bats and are usually not transmissible to humans. But when a coronavirus mutates, it can be passed from animals to humans. The new strain of coronavirus COVID-19 is one of the seven known coronaviruses that can infect humans causing fever and respiratory infections. China's National Health Commission has confirmed the virus can be transmitted between humans through direct contact, airborne droplets. Faecal-oral transmission could also be possible. Although the death toll of COVID-19 has surpassed that of SARS, its fatality rate is relatively low compared to other deadly coronavirus, such as SARS and MERS.

COVID-19: Number of Death: Year to Date: Shanghai data was reported at 595.000 Person in 08 Jan 2023. This stayed constant from the previous number of 595.000 Person for 07 Jan 2023. COVID-19: Number of Death: Year to Date: Shanghai data is updated daily, averaging 7.000 Person from Jan 2020 (Median) to 08 Jan 2023, with 1080 observations. The data reached an all-time high of 595.000 Person in 08 Jan 2023 and a record low of 1.000 Person in 18 Feb 2020. COVID-19: Number of Death: Year to Date: Shanghai data remains active status in CEIC and is reported by National Health Commission. The data is categorized under High Frequency Database’s Disease Outbreaks – Table CN.GZ: COVID-19: No of Death.